» Articles » PMID: 17666500

Prevalence of Dementia in Intellectual Disability Using Different Diagnostic Criteria

Overview
Journal Br J Psychiatry
Specialty Psychiatry
Date 2007 Aug 2
PMID 17666500
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diagnosis of dementia is complex in adults with intellectual disability owing to their pre-existing deficits and different presentation.

Aims: To describe the clinical features and prevalence of dementia and its subtypes, and to compare the concurrent validity of dementia criteria in older adults with intellectual disability.

Method: The Becoming Older with Learning Disability (BOLD) memory study is a two-stage epidemiological survey of adults with intellectual disability without Down syndrome aged 60 years and older, with comprehensive assessment of people who screen positive. Dementia was diagnosed according to ICD-10, DSM-IV and DC-LD criteria.

Results: The DSM-IV dementia criteria were more inclusive. Diagnosis using ICD-10 excluded people with even moderate dementia. Clinical subtypes of dementia can be recognised in adults with intellectual disability. Alzheimer's dementia was the most common, with a prevalence of 8.6% (95% CI 5.2-13.0), almost three times greater than expected.

Conclusions: Dementia is common in older adults with intellectual disability, but prevalence differs according to the diagnostic criteria used. This has implications for clinical practice.

Citing Articles

The Incidence and Prevalence of Dementia Among Ontario Adults With and Without Intellectual and Developmental Disabilities.

Patel P, Sun W, Mataruga A, Fung K, Balogh R Int J Geriatr Psychiatry. 2025; 40(2):e70050.

PMID: 39939115 PMC: 11821373. DOI: 10.1002/gps.70050.


Dementia in Rare Genetic Neurodevelopmental Disorders: A Systematic Literature Review.

Kwetsie H, van Schaijk M, van der Lee S, Maes-Festen D, Ten Hoopen L, van Haelst M Neurology. 2024; 102(11):e209413.

PMID: 38759134 PMC: 11175636. DOI: 10.1212/WNL.0000000000209413.


Iatrogenic Alzheimer's disease in recipients of cadaveric pituitary-derived growth hormone.

Banerjee G, Farmer S, Hyare H, Jaunmuktane Z, Mead S, Ryan N Nat Med. 2024; 30(2):394-402.

PMID: 38287166 PMC: 10878974. DOI: 10.1038/s41591-023-02729-2.


Symptoms and age of prodromal Alzheimer's disease in Down syndrome: a systematic review and meta-analysis.

Shimizu E, Goto-Hirano K, Motoi Y, Arai M, Hattori N Neurol Sci. 2024; 45(6):2445-2460.

PMID: 38228941 DOI: 10.1007/s10072-023-07292-9.


Common mental health disorders and cognitive decline in a longitudinal Down syndrome cohort.

Idris M, Saini F, Pape S, Baksh R, Cahart M, Strydom A BJPsych Open. 2023; 9(6):e206.

PMID: 37920115 PMC: 10753965. DOI: 10.1192/bjo.2023.590.